Compare Eli Lilly And Co (LLY) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Xpeng Inc - ADR — how do they compare? Eli Lilly And Co trades at $1,170.93 (market cap $1.02T), while Xpeng Inc - ADR trades at $13.35 (market cap $12.96B). The key difference: Eli Lilly And Co is far larger — about 78.7× Xpeng Inc - ADR's market cap, and Eli Lilly And Co pays a 0.6% dividend while Xpeng Inc - ADR pays none. Which is the better fit depends on your goals.
| LLY | XPEV | |
|---|---|---|
Market Cap | $1.02T | $12.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.24K | $28.07 |
52-Week Low | $625.65 | $12.09 |
Enterprise Value | $1.06T | $15.07B |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
